Hu, G, Khodadoust M, Konopleva M, Huang Z, Andreeff M

GLP-1R, a core member of the GPCR family, is widely present on the surfaces of various cells in the human body.1,2 By specifically binding to the key hormone GLP-1, it regulates blood glucose levels and lipid metabolism.3,4 This receptor and its agonists hold significant therapeutic potential, reshaping the treatment approaches for multiple diseases, including diabetes, cardiovascular disorders, and neurodegenerative diseases .5,6,7 GLP-1 is a peptide produced by the cleavage of proglucagon, mainly synthesized in the intestinal mucosal L-cells, pancreatic islet -cells, and neurons in the nucleus of the solitary tract.3,4 GLP-1RAs mimic the action of endogenous GLP-1, activating GLP-1R, thereby enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing food intake through central appetite suppression.8,9,10 These mechanisms make GLP-1RAs powerful tools for controlling blood glucose and improving metabolic syndrome

These include heart medication (digoxin), antifungal medicines, HIV medicines, anti-epileptic medicines (phenytoin), blood thinners (warfarin, clopidogrel), antibiotics such as rifampicin
The most reliable approach is to increase the dose slowly
Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
The synergistic combination of creatine monohydrate and HMB in our formula lets you push harder during workouts and achieve greater training adaptations (e.g muscle growth and strength increases)